We are live on ! Find out more
HC

Hampstead Capital Portfolio holdings

AUM $55.8M
1-Year Est. Return 2.76%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
+2.76%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$96.7M
AUM Growth
+$2.4M
Cap. Flow
+$1.65M
Cap. Flow %
1.71%
Top 10 Hldgs %
49.68%
Holding
29
New
–
Increased
10
Reduced
7
Closed
–

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.19M
2
WLK icon
Westlake Corp
WLK
+$949K
3
GILD icon
Gilead Sciences
GILD
+$703K
4
XOM icon
ExxonMobil
XOM
+$501K
5
RRC icon
Range Resources
RRC
+$463K

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$963K
2
AAPL icon
Apple
AAPL
+$922K
3
HPE icon
Hewlett Packard
HPE
+$832K
4
PM icon
Philip Morris
PM
+$475K
5
PFE icon
Pfizer
PFE
+$386K

Sector Composition

Rank Sector Weight
1 Healthcare 28.49%
2 Communication Services 17.53%
3 Energy 12.54%
4 Technology 11.01%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RTX icon
26
RTX Corp
RTX
$290B
$1.68M 1.74%
23,835
– –
CTRA
27
DELISTED
Coterra Energy
CTRA
$1.2M 1.24%
50,000
+17,000
+52% +$386K
AVP
28
DELISTED
Avon Products, Inc.
AVP
$660K 0.68%
150,000
+50,000
+50% +$250K
XPRO icon
29
Expro Ltd
XPRO
$1.79B
$423K 0.44%
6,667
– –
1
2

Similar funds

CCP
Centaur Capital Partners Southlake, Texas $54.1M AUM 12.4% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
CLA
Cranberry Lake Advisors Houston, Texas $50.6M AUM 5.12% 1-Year Est. Return
EIC
ENA Investment Capital London, United Kingdom $61.8M AUM
SF
Schooner Foundation Boston, Massachusetts $49.6M AUM 9.4% 1-Year Est. Return
DIV
DCM International V Menlo Park, California $47.8M AUM 19.52% 1-Year Est. Return
MGPI
Maveron General Partner III Seattle, Washington $46.7M AUM 35.29% 1-Year Est. Return
BOIA
Bush ODonnell Investment Advisors St Louis, Missouri $65.2M AUM 13.39% 1-Year Est. Return

Hampstead Capital's Q1 2017 Portfolio in Review

As of Q1 2017, Hampstead Capital held 29 positions worth $96.7M, up 2.6% from $94.3M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Trading was light in Q1 2017: portfolio turnover was 0%. Hampstead Capital opened no new positions and made no exits, leaving the 29-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Communication Services and Energy.

  • Hampstead Capital added most to Teva Pharmaceuticals in Q1 2017, an estimated $1.19M increase.
  • Hampstead Capital's biggest Q1 2017 reduction was American International, cutting an estimated $963K.
  • Hampstead Capital's ten largest holdings make up 50% of its $96.7M portfolio in Q1 2017.
  • Hampstead Capital opened 0 new positions and closed 0 in Q1 2017.
  • Hampstead Capital's portfolio value rose 2.6% quarter-over-quarter to $96.7M.

Based on Hampstead Capital's 13F filing for Q1 2017, filed 15 May 2017.